Phase II trial of efficacy, safety and biomarker analysis of sintilimab plus anlotinib for patients with recurrent or advanced endometrial cancer
=================================================================================================================================================

* Wei Wei
* Xiaohua Ban
* Fan Yang
* Jibin Li
* Xiaqin Cheng
* Rong Zhang
* Xin Huang
* Yongwen Huang
* Qiaqia Li
* Ya Qiu
* Min Zheng
* Xiaofeng Zhu
* Jundong Li